Skip to main content
. 2024 Jan 24:02537176231223314. Online ahead of print. doi: 10.1177/02537176231223314

Table 3.

Comparison of Adverse Effects in the Study Groups.

Adverse Effects Active Group (n = 17) N (%) Sham Group (n = 17) N (%) Relative risk (RR)
Numbness at stimulation site 5 (29.41) 2 (11.76)5 2.5
Burning at stimulation site 5 (29.41) 1 (5.88) 5
Pain 3 (17.64) 2 (11.76) 1.5
Headache 1 (5.88) 1 (5.88) 1
Tingling sensation 1 (5.88) 2 (11.76) 0.5
Sedation 2 (11.76) 0 (0.00)